Activation of the histamine H1-receptor (HRH1) drives oncogenic progression by engaging key survival cascades, including the ERK and NF-κB signaling pathways, which collectively enhance tumor cell growth and confer resistance to programmed cell death [15,16]. Here, HRH1 is linked to neoplasm.